As a small biotechnology company associated with one of the largest and most research intensive transplant programs in the world we are uniquely placed to take advantage of a dynamic research feed stream. We realize however that there are limitations on what we can achieve on our own and are vision is to partner with the pharma industry to fully exploit our current and future pipeline of products. Towards that end we are targeting forming partnerships with larger corporations that have the resources to take our research and development leads to full commercialization. The choice of partners will be determined by two criteria: 1) Commitment to fast track research and development targets to commercial clinical use. 2) Financial commitment to support the basic research and development pipeline.